Pala won't accept anything lower.The capex costs will be much lower than SDL etc, especially since investigations are now focused on smaller scale production
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025